Approvals/CIMA-AEMPS/DALBAVANCINA SALA 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Approved

STANDARD

DALBAVANCINA SALA 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Laboratorio Reig Jofre, S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: cf55b02e814ec8c5
Drug Cima Aemps Name: DALBAVANCINA SALA 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number: 89545
Holder Company Name: Laboratorio Reig Jofre, S.A.
Marketing Company Name: Laboratorio Reig Jofre, S.A.
Authorization Date: 2024-05-07
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 500 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Laboratorio Reig Jofre, S.A.

DALBAVANCINA

500 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 7, 2024

Approval ID

cf55b02e814ec8c5

Type

Standard